ECGI To Acquire East West Pharma Group
ECGI To Acquire East West Pharma Group
ECGI Holdings Inc. (OTCPK:ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, signed a letter of intent with East West Pharma Group, Inc., a Wyoming corporation, outlining the terms under which ECGI will acquire the key personnel, intellectual property, and current and future business operations of EWPG.
心電 控股公司。 (OTCPK: 心電), D/B/精英大麻集團成立一家總部位於內華達的投資組合公司，正在進入合法的大麻和大麻素市場，簽署了 意向書 與 東西醫藥集團股份有限公司懷俄明州的一家公司，概述了 ECGI 的條款 將獲得 EWPG 的關鍵人員，智慧財產權以及當前和未來的業務運營。
"This is a key talent and asset acquisition that will expand our network of potential investors through the lead operations team we get as part of the deal," stated ECGI CEO, Danny Wong. "East West has extensive knowledge and proprietary technology/processes within the CBD & eastern medicine field, and we will gain a tremendous base of specialized equipment as well as key personnel that include leaders in the cannabinoid extraction and product manufacturing space."
ECGI 首席執行官表示：「這是一項關鍵的人才和資產收購，將通過我們獲得的主要運營團隊擴大我們的潛在投資者網絡，」ECGI 首席執行官表示， 丹尼·黃。「East West 在 CBD 和東部醫學領域擁有廣泛的知識和專有技術/流程，我們將獲得巨大的專業設備基礎以及關鍵人員，其中包括大麻素提取和產品製造領域的領導者。」
Management notes that this acquisition is a shift in the company's strategy by becoming part of the cannabis manufacturing, extract and concentrates market.
管理層指出，通過成為大麻製造，提取和集中市場的一部分，這次收購是公司戰略的轉變。
According to East West Pharma Group, the extraction equipment was custom built to process very large volumes of industrial hemp (up to 500 pounds per hour) and distill crude material through a high-volume liquid to liquid (L2L) process designed to generate optimal refined product.
根據東西醫藥集團的說法，該提取設備是定制的，以處理大量的工業大麻（高達 500 每小時磅），並通過大容量液體到液體（L2L）過程提煉原料，旨在生產最佳的精煉產品。
The rare combination of industrial scale processing with fine quality distillation was the design brainchild of Dr. Zhihong Zhou, Ph.D., the dean of extraction of Yunnan University, School of Traditional Chinese Medicine. Key personnel assets incorporated into the acquisition include Dr. Zhou, Stanley Zhang, and Sam Lai.
工業規模加工與優質蒸餾的罕見組合是設計的心血結晶 周志宏博士博士，雲南大學中醫藥學院提取院長。此次收購中納入的主要人事資產包括周博士、張鴻燊和黎三。
Benzinga's Cannabis Capital Conference Is Back
本辛加的大麻資本會議又回來了
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Donâ€t miss out. Secure your tickets now. Prices will surge very soon.
世界上最成功的大麻商業活動 Beninga 大麻資本會議將返回邁阿密參加第 16 版。這是交易完成的地方，在那裡籌集資金，併購開始，公司會見投資者和主要合作夥伴。加入我們在佛羅里達州楓丹白露邁阿密海灘酒店 4 月 11 日至 12 日。多納 € 不會錯過了。立即保護您的門票。價格很快就會激增。
Photo: Benzinga edit with photos by geralt and lindsayfox on Pixabay
照片：賓辛加編輯與照片由傑洛特和林德塞福克斯在皮克斯卡貝
譯文內容由第三人軟體翻譯。